Pharmaceutical Company Rankings by Revenue year-over-year growth rate
Compare Japanese listed companies using EDINET financial data across metrics such as revenue, margins, ROE, and growth.
For Pharmaceutical by Revenue year-over-year growth rate, the top 5 companies are 株式会社サイフューズ (324.3%), 株式会社PRISM BioLab (121.6%), Nano Holdings, Inc. (60.8%), RIBOMIC Inc. (42.4%), ソレイジア・ファーマ株式会社 (35.8%). 61 of 82 companies in the selected population have usable Revenue year-over-year growth rate data. The ranking uses each company’s latest annual data; fiscal periods may differ. Companies ranked sixth and below are also shown in the ranking table below.
Compare industries by Median Revenue Year-over-Year Growth RateRanking metrics
※ Deposits, lending, and securities investment have a large impact on financial companies, so FCF, FCF margin, and FCF growth may not be suitable for simple comparisons with other industries.
Company ranking chart
Company ranking table
| Rank | Company | Industry | Fiscal year | Revenue year-over-year growth rate |
|---|---|---|---|---|
| 1 | 株式会社サイフューズ | Pharmaceutical | FY2025 | 324.3% |
| 2 | 株式会社PRISM BioLab | Pharmaceutical | FY2025 | 121.6% |
| 3 | Nano Holdings, Inc. | Pharmaceutical | FY2026 | 60.8% |
| 4 | RIBOMIC Inc. | Pharmaceutical | FY2026 | 42.4% |
| 5 | ソレイジア・ファーマ株式会社 | Pharmaceutical | FY2025 | 35.8% |
| 6 | Kidswell Bio Corporation | Pharmaceutical | FY2026 | 29.7% |
| 7 | WAKAMOTO PHARMACEUTICAL CO.,LTD. | Pharmaceutical | FY2026 | 27.2% |
| 8 | JCR Pharmaceuticals Co.,Ltd. | Pharmaceutical | FY2026 | 21.9% |
| 9 | Cuorips Inc. | Pharmaceutical | FY2026 | 21.2% |
| 10 | MUROMACHI CHEMICALS INC. | Pharmaceutical | FY2026 | 17.9% |
Source: FSA EDINET / Data and metrics: bestforever.jp
New EDINET filings are typically imported within minutes, with financial data and analysis results updated accordingly.